Literature DB >> 32880435

Engineering a Virus-like Particle to Display Peptide Insertions Using an Apparent Fitness Landscape.

Stephanie A Robinson1,2, Emily C Hartman1, Bon C Ikwuagwu2, Matthew B Francis1,3, Danielle Tullman-Ercek2.   

Abstract

Peptide insertions in the primary sequence of proteins expand functionality by introducing new binding sequences, chemical handles, or membrane disrupting motifs. With these properties, proteins can be engineered as scaffolds for vaccines or targeted drug delivery vehicles. Virus-like particles (VLPs) are promising platforms for these applications since they are genetically simple, mimic viral structure for cell uptake, and can deliver multiple copies of a therapeutic agent to a given cell. Peptide insertions in the coat protein of VLPs can increase VLP uptake in cells by increasing cell binding, but it is difficult to predict how an insertion affects monomer folding and higher order assembly. To this end, we have engineered the MS2 VLP using a high-throughput technique, called Systematic Mutagenesis and Assembled Particle Selection (SyMAPS). In this work, we applied SyMAPS to investigate a highly mutable loop in the MS2 coat protein to display 9,261 non-native tripeptide insertions. This library generates a discrete map of three amino acid insertions permitted at this location, validates the FG loop as a valuable position for peptide insertion, and illuminates how properties such as charge, flexibility, and hydrogen bonding can interact to preserve or disrupt capsid assembly. Taken together, the results highlight the potential to engineer VLPs in a systematic manner, paving the way to exploring the applications of peptide insertions in biomedically relevant settings.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32880435      PMCID: PMC7959485          DOI: 10.1021/acs.biomac.0c00987

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  37 in total

Review 1.  Bioengineering virus-like particles as vaccines.

Authors:  Linda H L Lua; Natalie K Connors; Frank Sainsbury; Yap P Chuan; Nani Wibowo; Anton P J Middelberg
Journal:  Biotechnol Bioeng       Date:  2013-12-17       Impact factor: 4.530

2.  Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.

Authors:  Ebenezer Tumban; Pavan Muttil; Carolina Andrea A Escobar; Julianne Peabody; Denis Wafula; David S Peabody; Bryce Chackerian
Journal:  Vaccine       Date:  2015-05-21       Impact factor: 3.641

3.  Deviations from standard atomic volumes as a quality measure for protein crystal structures.

Authors:  J Pontius; J Richelle; S J Wodak
Journal:  J Mol Biol       Date:  1996-11-22       Impact factor: 5.469

4.  Systematic Engineering of a Protein Nanocage for High-Yield, Site-Specific Modification.

Authors:  Daniel D Brauer; Emily C Hartman; Daniel L V Bader; Zoe N Merz; Danielle Tullman-Ercek; Matthew B Francis
Journal:  J Am Chem Soc       Date:  2019-02-20       Impact factor: 15.419

5.  Experimental Evaluation of Coevolution in a Self-Assembling Particle.

Authors:  Emily C Hartman; Marco J Lobba; Andrew H Favor; Stephanie A Robinson; Matthew B Francis; Danielle Tullman-Ercek
Journal:  Biochemistry       Date:  2018-12-06       Impact factor: 3.162

6.  Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.

Authors:  Amir Abbas Mokhtarieh; Semi Kim; Yunhee Lee; Bong Hyun Chung; Myung Kyu Lee
Journal:  Biochem Biophys Res Commun       Date:  2013-02-04       Impact factor: 3.575

7.  The characterization of amino acid sequences in proteins by statistical methods.

Authors:  J M Zimmerman; N Eliezer; R Simha
Journal:  J Theor Biol       Date:  1968-11       Impact factor: 2.691

8.  Crystal structures of MS2 capsids with mutations in the subunit FG loop.

Authors:  N J Stonehouse; K Valegård; R Golmohammadi; S van den Worm; C Walton; P G Stockley; L Liljas
Journal:  J Mol Biol       Date:  1996-02-23       Impact factor: 5.469

9.  A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9.

Authors:  Lukai Zhai; Julianne Peabody; Yuk-Ying Susana Pang; John Schiller; Bryce Chackerian; Ebenezer Tumban
Journal:  Antiviral Res       Date:  2017-09-20       Impact factor: 5.970

10.  Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform.

Authors:  Jerri Caldeira; Jeremiah Bustos; Julianne Peabody; Bryce Chackerian; David S Peabody
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

View more
  3 in total

Review 1.  Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines.

Authors:  Chiara Rinoldi; Seyed Shahrooz Zargarian; Pawel Nakielski; Xiaoran Li; Anna Liguori; Francesca Petronella; Dario Presutti; Qiusheng Wang; Marco Costantini; Luciano De Sio; Chiara Gualandi; Bin Ding; Filippo Pierini
Journal:  Small Methods       Date:  2021-07-28

2.  Microcompartment assembly around multicomponent fluid cargoes.

Authors:  Lev Tsidilkovski; Farzaneh Mohajerani; Michael F Hagan
Journal:  J Chem Phys       Date:  2022-06-28       Impact factor: 4.304

3.  Programmable polymorphism of a virus-like particle.

Authors:  Artur P Biela; Antonina Naskalska; Farzad Fatehi; Reidun Twarock; Jonathan G Heddle
Journal:  Commun Mater       Date:  2022-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.